U.S. Stem Cell, Inc.: Court Reports Favorable Judgment in California Stem Cell Case
SUNRISE, FL / ACCESSWIRE / September 1, 2022 / U.S. Stem Cell, Inc. (OTC:USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions
Source: finanznachrichten.de